Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
Authors:
- Takuro KamedaTKTakuro Kameda
- Kotaro ShideKSKotaro Shide
- Yuki TahiraYTYuki Tahira
- Masaaki SekineMSMasaaki Sekine
- Seiichi SatoSSSeiichi Sato
- Junzo IshizakiJIJunzo Ishizaki
- Masanori TakeuchiMTMasanori Takeuchi
- Keiichi AkizukiKAKeiichi Akizuki
- Ayako KamiuntenAKAyako Kamiunten
- Haruko ShimodaHSHaruko Shimoda
- Takanori ToyamaTTTakanori Toyama
- Kouichi MaedaKMKouichi Maeda
Open Access
Abstract
A retrospective chart survey of the clinical features of indolent adult T-cell leukemia/lymphoma (ATL) was conducted in the Miyazaki Prefecture, Japan. This study enrolled 24 smoldering-type ATLs, 10 favorable chronic-type ATLs, and 20 unfavorable chronic-type ATLs diagnosed between 2010 and 2018. Among them, 4, 3, and 10 progressed to acute-type ATLs during their clinical course. The median survival time (MST) in smoldering-type ATL and favorable chronic-type ATL was not reached, and their 4-year overall survival (OS) was 73% and 79%, respectively. Compared with this, the prognosis of unfavorable chronic-type ATL was poor. Its MST was 3.32 years, and the 4-year OS was 46% (p = 0.0095). In addition to the three features that determine the unfavorable characteristics of chronic-type ATL, namely, increased lactate dehydrogenase, increased blood urea nitrogen, and decreased albumin, the high-risk category by the indolent ATL-Prognostic Index, which was defined by an increment of soluble interleukin-2 receptor (sIL2-R) of >6000 U/mL, could explain the poor prognosis in indolent ATL patients. The level of sIL-2R might be an indicator of the initiation of therapy for indolent ATL.Keywords
Funding Information
- University of Miyazaki (R3)
This publication has 10 references indexed in Scilit:
- Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphomaEuropean Journal of Haematology, 2020
- Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based studyCancer Science, 2020
- Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia LymphomaFrontiers in Microbiology, 2020
- Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphomaBlood, 2017
- Treatment and survival among 1594 patients with ATLBlood, 2015
- Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/LymphomaJournal of Clinical Oncology, 2012
- Long-term study of indolent adult T-cell leukemia-lymphomaBlood, 2010
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008
- Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphomaBritish Journal of Haematology, 1991
- Adult T-cell leukemia: clinical and hematologic features of 16 casesBlood, 1977